Treatment of Metastatic Renal Cell Carcinoma With Nephrectomy, Interleukin-2 and Cytokine-Primed or CD8(+) Selected Tumor Infiltrating Lymphocytes from Primary Tumor-Reference-Cited by-同舟云学术

Treatment of Metastatic Renal Cell Carcinoma With Nephrectomy, Interleukin-2 and Cytokine-Primed or CD8(+) Selected Tumor Infiltrating Lymphocytes from Primary Tumor

Published:1997-09 Issue:3 Volume:158 Page:740-745
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Figlin Robert A.¹,Pierce William C.¹,Kaboo Randir¹,Tso Cho Lea¹,Moldawer Nancy¹,Gitlitz Barbara¹,deKernion Jean¹,Belldegrun Arie¹

Affiliation:

1. From the Department of Medicine, Division of Hematology Oncology, and Department of Surgery, Division of Urology, UCLA School of Medicine, Jonsson Comprehensive Cancer Center, Los Angeles, California.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference26 articles.

1. Cancer Statistics, 1996.;Parker;CA Cancer J. Clin.,1996

2. SEER Cancer Statistics Review, 1973-1990.,1990

3. Renal cell carcinoma: long-term survival and late recurrence.;McNichols;J. Urol.,1981

4. Renal cell carcinoma: survival and prognostic factors.;Golimbu;Urology,1986

5. Validation of the tumor, nodes and metastasis classification of renal cell carcinoma.;Bassil;J. Urol.,1985

Cited by 139 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Generation and Characterization of Ex Vivo Expanded Tumor-infiltrating Lymphocytes From Renal Cell Carcinoma Tumors for Adoptive Cell Therapy;Journal of Immunotherapy;2024-07-15

2. Developing innovative strategies of tumor‑infiltrating lymphocyte therapy for tumor treatment;Oncology Reports;2024-04-26

3. Lifileucel, an Autologous Tumor-Infiltrating Lymphocyte Monotherapy, in Patients with Advanced Non–Small Cell Lung Cancer Resistant to Immune Checkpoint Inhibitors;Cancer Discovery;2024-04-01

4. Revisiting mechanisms of resistance to immunotherapies in metastatic clear-cell renal-cell carcinoma;Cancer Drug Resistance;2023

5. Tumor-infiltrating lymphocytes for treatment of solid tumors: It takes two to tango?;Frontiers in Immunology;2022-10-28